Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Giese

Showing results (181-190 of 208) with videos related to

Pageof 21
Sort By:
Plos One|January 19, 2012
S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitisLisa Reinhard, Christian Rupp, Hans-Dieter Riedel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2011
Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cellsSascha Dietrich, Oliver H Krämer, Esther Hahn, et al.
Nature Medicine|October 20, 2015
Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progressionMuhammad S Alam, Matthias M Gaida, Frank Bergmann, et al.
International Journal of Cancer|May 13, 2016
Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapyAleksandar Radujkovic, Sascha Dietrich, Mindaugas Andrulis, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2013
Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiencyJohann Greil, Tobias Rausch, Thomas Giese, et al.
Respiration; International Review of Thoracic Diseases|April 1, 2019
Disseminated Mycosis by Arthrocladium fulminans Jeopardizing a Patient with GATA2 DeficiencyBenjamin Egenlauf, Maren Schuhmann, Thomas Giese, et al.
Frontiers in Nephrology|March 6, 2024
A multi-center interventional study to assess pharmacokinetics, effectiveness, and tolerability of prolonged-release tacrolimus after pediatric kidney transplantation: study protocol for a prospective, open-label, randomized, two-phase, two-sequence, single dose, crossover, phase III b trialSinem Karaterzi, Burkhard Tönshoff, Thurid Ahlenstiel-Grunow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2012
New gene-immunotherapy combining TRAIL-lymphocytes and EpCAMxCD3 Bispecific antibody for tumor targetingAriane Groth, Alexei V Salnikov, Sabine Ottinger, et al.
JCI Insight|December 12, 2022
The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancerKilian B Kennel, Julius Burmeister, Praveen Radhakrishnan, et al.
Oncotarget|March 17, 2018
Endogenous CHRNA7-ligand SLURP1 as a potential tumor suppressor and anti-nicotinic factor in pancreatic cancerVerena M Throm, David Männle, Thomas Giese, et al.
Pageof 21

Showing results (181-190 of 208) with videos related to

Sort By:
Pageof 21
Plos One|January 19, 2012
S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitisLisa Reinhard, Christian Rupp, Hans-Dieter Riedel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2011
Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cellsSascha Dietrich, Oliver H Krämer, Esther Hahn, et al.
Nature Medicine|October 20, 2015
Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progressionMuhammad S Alam, Matthias M Gaida, Frank Bergmann, et al.
International Journal of Cancer|May 13, 2016
Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapyAleksandar Radujkovic, Sascha Dietrich, Mindaugas Andrulis, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2013
Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiencyJohann Greil, Tobias Rausch, Thomas Giese, et al.
Respiration; International Review of Thoracic Diseases|April 1, 2019
Disseminated Mycosis by Arthrocladium fulminans Jeopardizing a Patient with GATA2 DeficiencyBenjamin Egenlauf, Maren Schuhmann, Thomas Giese, et al.
Frontiers in Nephrology|March 6, 2024
A multi-center interventional study to assess pharmacokinetics, effectiveness, and tolerability of prolonged-release tacrolimus after pediatric kidney transplantation: study protocol for a prospective, open-label, randomized, two-phase, two-sequence, single dose, crossover, phase III b trialSinem Karaterzi, Burkhard Tönshoff, Thurid Ahlenstiel-Grunow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2012
New gene-immunotherapy combining TRAIL-lymphocytes and EpCAMxCD3 Bispecific antibody for tumor targetingAriane Groth, Alexei V Salnikov, Sabine Ottinger, et al.
JCI Insight|December 12, 2022
The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancerKilian B Kennel, Julius Burmeister, Praveen Radhakrishnan, et al.
Oncotarget|March 17, 2018
Endogenous CHRNA7-ligand SLURP1 as a potential tumor suppressor and anti-nicotinic factor in pancreatic cancerVerena M Throm, David Männle, Thomas Giese, et al.
Pageof 21